A landmark PROTEUS trial published in Nature Medicine (June 2026) demonstrates that combining perioperative androgen-deprivation therapy with apalutamide offers a new treatment pathway for high-risk, localized prostate cancer, potentially reducing biochemical recurrence when administered before radical prostatectomy. โ Photo by Logan Gutierrez on Unsplash (Unsplash License)
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accrรฉditation Sans Frontiรจres (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016โ2021). ORCID: 0000-0001-7609-4515.
